Joss N, Staatz C E, Thomson A H, et al. Predictors of new onset diabetes after renal transplantation[J]. Clin Transplant ,2007, 19:136-143.
[1]
Montori V M, Basu A, Erwin P J, et al. Posttransplantation diabetes: a systematic review of the literature[J]. Diabetes Care ,2002, 25:583-592.
[6]
Hjelmesth J,Sagedal S,Hartmann A,et al.Cytomegalovirus infection is associated with increased risk for new-onset diabetes and impaired insulin release after renal transplantation[J]. Diabetologia,2004,10:1007/s00125-004-1499-z.
[2]
Miles A M V,Sumrani N,Horowitz R,et al.Diabetes mellitus after renal.transplantation[J]. Transplantation, 1998,65: 380.
[7]
Knobler H, Stagnaro-Green A, Wallenstein S, et al. Higher incidence of diabetes in liver transplant recipients with hepatitis C[J]. J Clin Gastroenterol, 1998,26: 30-33.
[8]
Baid S,Cosimi A B,Farrell M L,et al.Post-transplant diabetes mellitus in liver transplant recipients:Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality[J]. Transplantation,2001,72: 1066-1072.
[3]
Baid S,Cosimi A B,Farrell M L,et al.Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with Hepatitis C virus allograft hepatitis, and impact on mortality[J]. Transplantation ,2001,72: 1066.
[9]
Bloom R D, Rao V, Weng F, et al. Association of hepatitis C with post-transplant diabetes in renal transplant patients on tacrolimus[J]. J Am Soc Nephrol,2002, 13:1374-1380.
[4]
Shah T,Kasravi A,Huang E, et al.Risk factors for development of new-onset diabetes mellitus after transplantation[J]. Transplantation, 2006, 82:1673-1676.
[10]
Khalili M,Lim J W,Bass N,et al.New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection[J]. Liver Transpl,2004,10: 349-355.
[5]
Joss N, Staatz C E, Thomson A H, et al. Predictors of new onset diabetes after renal transplantation[J]. Clin Transplant ,2007, 19:136-143.
[11]
Vincenti F, Friman S, Scheuermann E, et al. On behalf of the DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) Investigators: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J]. Am J Transpl,2007, 7:1506-1514.
[6]
Hjelmesth J,Sagedal S,Hartmann A,et al.Cytomegalovirus infection is associated with increased risk for new-onset diabetes and impaired insulin release after renal transplantation[J]. Diabetologia,2004,10:1007/s00125-004-1499-z.
[12]
Panz V R, Bonegio R, Raal F J, et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1[J]. Transplantation, 2002,73(4):587-590.
[7]
Knobler H, Stagnaro-Green A, Wallenstein S, et al. Higher incidence of diabetes in liver transplant recipients with hepatitis C[J]. J Clin Gastroenterol, 1998,26: 30-33.
[8]
Baid S,Cosimi A B,Farrell M L,et al.Post-transplant diabetes mellitus in liver transplant recipients:Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality[J]. Transplantation,2001,72: 1066-1072.
[13]
Midtvedt K,Hjelmesaeth J,Hartmann A,et al.Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal[J]. J Am Soc Nephrol ,2004, 15:3233-3239.
[14]
Qing Yuan Li,Feng Li,Ji Hua Sun, et al. Mechanisms of diabetes mellitus induced with FK506 in SD rats models[J]. Immunopharmacology and Immunotoxicology, 2009,31(4): 675-681.
[9]
Bloom R D, Rao V, Weng F, et al. Association of hepatitis C with post-transplant diabetes in renal transplant patients on tacrolimus[J]. J Am Soc Nephrol,2002, 13:1374-1380.
[10]
Khalili M,Lim J W,Bass N,et al.New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection[J]. Liver Transpl,2004,10: 349-355.
[15]
Plaumann S,Blume R. Activation of the dual-leucine-zipper- bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A[J]. Mol Pharmacol, 2008,73(3):652-659.
[11]
Vincenti F, Friman S, Scheuermann E, et al. On behalf of the DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) Investigators: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J]. Am J Transpl,2007, 7:1506-1514.
[16]
Drachenberg C B, Klassen D K, Weir M R,et al.Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation[J]. Transplantation,1999,68:396-402.
Panz V R, Bonegio R, Raal F J, et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1[J]. Transplantation, 2002,73(4):587-590.
[18]
Oetjen E,Baun D,Beimesche S,et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice[J]. Mol Pharmacol,2003, 63: 1289-1295.
[13]
Midtvedt K,Hjelmesaeth J,Hartmann A,et al.Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal[J]. J Am Soc Nephrol ,2004, 15:3233-3239.
[14]
Qing Yuan Li,Feng Li,Ji Hua Sun, et al. Mechanisms of diabetes mellitus induced with FK506 in SD rats models[J]. Immunopharmacology and Immunotoxicology, 2009,31(4): 675-681.
Plaumann S,Blume R. Activation of the dual-leucine-zipper- bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A[J]. Mol Pharmacol, 2008,73(3):652-659.
Drachenberg C B, Klassen D K, Weir M R,et al.Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation[J]. Transplantation,1999,68:396-402.
Davidson J, Wilkinson A, Dantal J, et al. International Expert Panel: New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an International Expert Panel meeting[J]. Transplantation ,2003, 75(Suppl 10):S3-S24.
[18]
Oetjen E,Baun D,Beimesche S,et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice[J]. Mol Pharmacol,2003, 63: 1289-1295.
[22]
Luan F L, Steffi ck D E, Gadegbeku C, et al. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression[J]. Am J Transplant ,2009, 9:160-168.
[23]
Ghisdal L, Bouchta N B, Broeders N, et al. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature[J]. Transpl Int, 2008, 21:146-151.
Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia[J]. Transplantation,2008, 85:353-358.
[21]
Davidson J, Wilkinson A, Dantal J, et al. International Expert Panel: New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an International Expert Panel meeting[J]. Transplantation ,2003, 75(Suppl 10):S3-S24.
[22]
Luan F L, Steffi ck D E, Gadegbeku C, et al. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression[J]. Am J Transplant ,2009, 9:160-168.
[26]
Kurian B,Joshi R,Helmuth A.Effectiveness and longterm safety of thiazolidinediones and metformin in renal transplant recipients[J]. Endocrinol Pract, 2008, 14:979-984.
[23]
Ghisdal L, Bouchta N B, Broeders N, et al. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature[J]. Transpl Int, 2008, 21:146-151.
[27]
Türk T, Pietruck F, Dolff S, et al. Repaglinide in the management of new-onset diabetes mellitus after renal transplantation[J]. Am J Transplant,2006, 6:842-846.
Shen Z Y, Niu Y J,Xu C, et al. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus[J]. Clinical Laboratory, 2013,59:869-874.
[25]
Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia[J]. Transplantation,2008, 85:353-358.
[26]
Kurian B,Joshi R,Helmuth A.Effectiveness and longterm safety of thiazolidinediones and metformin in renal transplant recipients[J]. Endocrinol Pract, 2008, 14:979-984.
[27]
Türk T, Pietruck F, Dolff S, et al. Repaglinide in the management of new-onset diabetes mellitus after renal transplantation[J]. Am J Transplant,2006, 6:842-846.
Shen Z Y, Niu Y J,Xu C, et al. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus[J]. Clinical Laboratory, 2013,59:869-874.
2014, Vol. 25 
